| |
| |
|
| Insider
Information: |
Riggs Rory B |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,917,677 |
|
|
Indirect Shares
|
724,607 |
|
|
| Direct
Value |
$38,228,958 |
|
|
|
Indirect Value
|
$3,545,853 |
|
|
| Total
Shares |
4,642,284 |
|
|
| Total
Value |
$41,774,812 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
30
|
|
Stock
price went up :
|
0
|
12
|
| Stock
price went down : |
3
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -18.1%
|
-178.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
Director |
2021-05-26 |
395,750 |
2021-05-26 |
605,713 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-02-20 |
320,099 |
2024-02-20 |
100,187 |
Premium* |
|
|
Cibus Inc |
CBUS |
|
2024-06-11 |
3,201,828 |
2024-06-11 |
18,707 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2002-12-12 |
4 |
S |
$41.98 |
$1,679,684 |
D/D |
(40,010) |
96,712 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-11 |
4 |
S |
$27.56 |
$675,927 |
D/D |
(24,429) |
505,771 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-14 |
4 |
S |
$27.56 |
$704,737 |
D/D |
(25,571) |
480,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2016-12-16 |
4 |
S |
$20.87 |
$417,310 |
D/D |
(20,000) |
460,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2017-09-13 |
4 |
S |
$51.92 |
$1,298,000 |
D/D |
(25,000) |
435,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-09 |
4 |
S |
$55.75 |
$1,276,954 |
D/D |
(22,905) |
411,295 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-12 |
4 |
S |
$54.98 |
$1,082,721 |
D/D |
(19,693) |
391,602 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-13 |
4 |
S |
$53.07 |
$671,743 |
D/D |
(12,402) |
379,200 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-10-20 |
4 |
S |
$42.00 |
$19,454,400 |
D/D |
(463,200) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-07 |
4 |
S |
$45.26 |
$12,385,399 |
I/I |
(273,650) |
2,081,540 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-25 |
4 |
S |
$42.69 |
$28,474,019 |
I/I |
(666,464) |
4,099,706 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-28 |
4 |
S |
$42.11 |
$7,051,269 |
I/I |
(167,448) |
3,932,258 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-29 |
4 |
S |
$41.26 |
$19,844,846 |
I/I |
(481,000) |
3,451,258 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-28 |
4 |
S |
$36.75 |
$1,470,088 |
D/D |
(40,000) |
639,760 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
S |
$36.31 |
$2,318,494 |
I/I |
(63,777) |
2,074,540 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
S |
$36.50 |
$899,706 |
D/D |
(24,648) |
615,112 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-11-16 |
4 |
S |
$42.01 |
$527,805 |
D/D |
(12,565) |
684,833 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-11-17 |
4 |
S |
$42.33 |
$5,902,285 |
I/I |
(139,389) |
1,115,645 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-11-17 |
4 |
S |
$42.39 |
$2,646,401 |
D/D |
(62,435) |
622,398 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-12-28 |
4 |
S |
$40.21 |
$4,400,415 |
I/I |
(109,448) |
673,052 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-12-29 |
4 |
S |
$40.00 |
$3,000,353 |
D/D |
(75,000) |
592,748 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-18 |
4 |
S |
$39.38 |
$5,110,675 |
I/I |
(129,222) |
85,187 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-21 |
4 |
S |
$39.05 |
$1,556,846 |
I/I |
(39,867) |
0 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-03-29 |
4 |
S |
$38.59 |
$2,315,322 |
D/D |
(60,000) |
601,712 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-05-19 |
4 |
S |
$40.09 |
$1,054,651 |
D/D |
(26,304) |
575,408 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
